SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks quarterly results and outlook are driving discussion: earnings and comparable sales beat expectations, but revenue missed, with the China restructuring weighing on reported sales, and shares declined. Bulls point to improving U.S. traffic and turnaround progress, while bears focus on the revenue miss, soft reported growth outlook and valuation.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Progress toward the Valaris merger including reported final Brazilian regulatory approvalhas renewed attention on RIG, with bullish traders citing the combined offshore fleet, contract backlog and elevated short interest as potential tailwinds. Others remain wary of share dilution, debt and the stocks muted reaction to positive developments; merger completion is still pending.

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

MPC is drawing attention amid a powerful rally in refiners, with traders pointing to elevated crack spreads and tight refined-fuel supplies tied to geopolitical disruptions as support for refinery margins. The community is split between bullish momentum and expectations of a pullback, with some questioning whether unusually strong margins can last after the sectors sharp run.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

NNE is drawing attention amid a steep decline alongside other nuclear and small-modular-reactor stocks, with traders pointing to sector-wide weakness and questioning the valuation and commercialization prospects of a pre-revenue company. Some see the pullback as a buying opportunity tied to future AI data-center power demand, while others remain bearish on execution and dilution risks.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline sharply in 2027 has fueled concern about pricing and revenue for CorMedixs flagship product, alongside the steep selloff. Traders are divided over whether DaVitas preliminary, company-specific modeling signals a lasting commercial headwind or overstates the risk given uncertainty around future reimbursement and product adoption.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention as a proxy for private AI holdings, especially amid speculation about a potential Anthropic IPO. Bulls see the listing as a catalyst, while bears question the funds premium to NAV and point to dilution and claims that it reduced its Anthropic stake.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarins Q3 results marked its first profitable quarter in more than two years, while traders focused on its debt-free balance sheet and ongoing Barclays-led strategic review amid speculation about a sale or buyback. The discussion also weighs EMT2s missed primary progression endpoint against a favorable secondary overall-survival signal, with uncertainty about whether the cancer finding can be translated into regulatory or commercial value.

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through North America and International Personal Care segments. The North America segment consists of products encompassing each of daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care, and Feminine Care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Dallas, TX.

Kimberly-Clark Corp.

Kimberly-Clark is drawing attention after preliminary Q3 results topped expectations and the company reaffirmed its outlook; traders also point to easing Huggies-related concerns in China and progress toward financing and regulatory approval for the Kenvue acquisition. Reactions are constructive around defensive-staples demand and the mergers potential, though some remain wary of deal execution and the stocks recent weakness.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high ahead of the expected Q3 report has focused attention on BRIUMVI sales and earnings expectations, alongside recurring, unconfirmed buyout speculation. Some traders attribute the rally to short-covering, while others caution that takeover rumors have repeatedly failed to materialize.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

AEHR is drawing attention for a sharp selloff amid concerns about its rich valuation, execution, and weakening price action. Traders are debating whether the decline is overdone ahead of earnings, with bulls pointing to AI chip-testing demand and expected growth while bears question whether orders and guidance will justify expectations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TGTX Stock Hits Fresh 52-Week High Ahead Of Earnings Amid Buyout Buzz

Equity

Investors are now focused on the company’s projected third-quarter 2026 results, estimated for Monday, November 2.


ENPH Stock Drops After-Hours As Interest Rates And Tax Credit Expiry Hit US Solar Demand

CEO Badri Kothandaraman attributed the drop in U.S. sell-through to elevated interest rates and the expiration of tax credits on renewable energy system installations. 


SEDG Stock Slides After Deutsche Bank Tags It A Short-Term Sell

Deutsche Bank analyst Corinne Blanchard said elevated interest rates are weighing on SolarEdge products’ U.S. demand and sees risk to fourth-quarter and 2027 earnings.

ACAD Stock Clocks Worst Day In 2 Years After Alzheimer’s Psychosis Drug Misses Main Goal — Citi Cuts Drug’s Success Odds To 20%  

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.


KMX Stock Edges Higher: CarMax Shares Bounce As 145 Corporate Jobs Go Ahead Of Q2 Report

The company has cut 145 jobs or 4% of its corporate staff, The Wall Street Journal reported. 


AMRX Stock Advances As Generic To Ipsen’s Hormone Shot Gets FDA Nod 

The Food and Drug Administration (FDA) cleared a 120-milligram prefilled syringe that copies Ipsen’s Somatuline Depot, a long-acting under-the-skin injection.


WEN Stock Drops After Meritage Files For Bankruptcy — Will More Stores Close Next?  

One of Wendy’s franchisees, operating 314 Wendy’s restaurants across 15 states, or about 5% of Wendy’s U.S. system, filed a voluntary Chapter 11 petition on Thursday. 


Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?

American Eagle Drops Big Ad Campaigns, Chases the Checkout 

American Eagle posted a quarterly profit beat that leaned on a $161 million tariff refund on Wednesday. 


Why Is KNTK Stock Up 5% After-Hours? 

People familiar with the matter told Bloomberg that Kinetik is in the early stages of exploring alternatives and is working with advisers to prepare a potential sale process. 


iShares Trust - iShares Core S&P Small-Cap ETF

Bearish Sentiment

<ul class="summary-bullets"><li>According to data from Fiscal AI, analysts forecast roughly $0.36 in earnings per share and about $245 million in revenue.</li><li>In late August, rumors emerged that a U.S. biopharma with a market cap between $20 billion and $40 billion may be interested in acquiring TG Therapeutics; the company didn't confirm the rumors.&nbsp;</li><li>Besides commercializing intravenous Briumvi, TG &nbsp;is also testing a subcutaneous version of the drug and a CAR-T therapy azer-cel.</li></ul> Shares of TG Therapeutics (TGTX) jumped on Friday, setting a new 52-week high, advancing a multi-day climb ahead of the company’s third-quarter earnings and amid buyout rumors. &nbsp;The stock was trading 5% higher at the time of writing.<h2 class="st-heading-2">TGTX’s Upcoming Earnings</h2>Investors are now focused on the company’s projected third-quarter 2026 results, estimated for Monday, November 2. The company has not confirmed the date.According to data from Fiscal AI, analysts forecast roughly $0.36 in earnings per share and about $245 million in revenue. In the prior quarter, the company beat revenue expectations but missed on EPS while raising full-year guidance on BRIUMVI sales.BRIUMVI is the company’s sole approved product indicated for adults with relapsing forms of multiple sclerosis, a chronic, autoimmune disease of the central nervous system causing nerve damage. It is given as a one-hour intravenous infusion every 24 weeks after the initial doses and has gained regulatory clearance in the United States and several other markets. Recent quarterly results showed continued double-digit sequential growth in U.S. net sales, supporting raised annual revenue targets near $950 million globally.<h2 class="st-heading-2">TG Therapeutics’ Pipeline Updates</h2>Besides commercializing intravenous Briumvi, TG &nbsp;is also testing a subcutaneous version of the drug and a CAR-T therapy, azer-cel.On October 23, the company presented early-stage data for azer-cel in progressive multiple sclerosis at the MSToronto2026 meeting. In 26 treated participants, the regimen showed no high-grade CAR-T toxicities. Among evaluable patients, 89% had stable or improved disability scores at day 90, with evidence of B-cell depletion in blood and cerebrospinal fluid.According to data from Koyfin, seven of eight analysts covering TGTX rate it 'Buy' or higher, while one rates it 'Strong Sell.' The stock has a 12-month average price target of $69.71, representing a potential upside of over 10% from the stock’s last close.In late August, rumors emerged that a U.S. biopharma with a market cap between $20 billion and $40 billion may be interested in acquiring TG Therapeutics. The company didn't confirm the rumors.<h2 class="st-heading-2">How Did Stocktwits Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$TGTX" data-symbol-id="TGTX" href="https://stocktwits.com/symbol/TGTX" target="_blank">TGTX stock</a> jumped from 'bullish' to 'extremely bullish' territory over the past 24 hours, while message volume stayed at 'high' levels.A Stocktwits user voiced anticipation for a buyout for $15-$20 billion, noting that he is “not convinced, but it is possible.” He also highlighted the strong addressable market for Briumvi, once the subcutaneous version of the drug is also approved. Currently, only the intravenous version is commercially available; the subcutaneous version is in late-stage development.<stembedurl>https://stocktwits.com/CT_Biker/message/667783391</stembedurl>Another user, however, pinned the rally to good earnings instead of buyout anticipation.<stembedurl>https://stocktwits.com/DonutHole2/message/667775080</stembedurl>TGTX has more than doubled year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/door-dash-s-17-b-instacart-deal-draws-significant-street-attention-a-look-at-what-analysts-have-to-say/cZULGnnR9T6">DoorDash’s $17B Instacart Deal Draws Significant Street Attention – A Look At What Analysts Have To Say</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the TG Therapeutics logo is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Investors are now focused on the company’s projected third-quarter 2026 results, estimated for Monday, November 2.

iShares Core S&P Small-Cap ETF

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

IJR iShares Core S&P Small-Cap ETF

Fundamentals

Latest IJR News